Financhill
Back

Aytu BioPharma Quote, Financials, Valuation and Earnings

Aytu BioPharma Price Quote

$1.61
-0.02 (6.75%)
(Updated: November 23, 2024 at 5:26 AM ET)

Aytu BioPharma Key Stats

Sell
20
Aytu BioPharma (AYTU) is a Sell

Day range:
$1.50 - $1.63
52-week range:
$1.41 - $3.45
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.14
P/B ratio:
0.34%

Volume:
27.4K
Avg. volume:
35.7K
1-year change:
-35.06%
Market cap:
$10M
Revenue:
$81M
EPS:
$-1.53

How Much Does Aytu BioPharma Make?

Is Aytu BioPharma Growing As A Company?

  • What Is Aytu BioPharma's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.07%
  • What Is Aytu BioPharma's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Aytu BioPharma Stock Price Performance

  • Did Aytu BioPharma Stock Go Up Last Month?
    Aytu BioPharma share price went down by -26.24% last month
  • Did AYTU's Share Price Rise Over The Last Year?
    AYTU share price fell by -35.06% over the past 1 year

What Is Aytu BioPharma 52-Week High & Low?

Aytu BioPharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Aytu BioPharma?

  • How Much Debt Does Aytu BioPharma Have?
    Total long term debt quarterly is $16.6M
  • How Much Cash Does Aytu BioPharma Have?
    Cash and short term investments quarterly total is $20.1M
  • What Is Aytu BioPharma’s Book Value Per Share?
    Book value per share is 4.85

Is Aytu BioPharma Cash Flow Positive?

  • What Is AYTU Cash Flow From Operations?
    Cash flow from operations (TTM) is -$2.4M
  • What Is Aytu BioPharma’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $2.4M
  • What Is Aytu BioPharma’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $128K

Aytu BioPharma Return On Invested Capital

  • Is Management Doing A Good Job?
    AYTU return on invested capital is -13.36%
  • What Is Aytu BioPharma Return On Assets?
    ROA measures how assets are converting to revenues and is -4.99%
  • What Is AYTU Return On Equity?
    ROE is a measure of profitability and is -20.38%

Aytu BioPharma Earnings Date & Stock Price

Aytu BioPharma Competitors

  • Who Are Aytu BioPharma's Competitors?
    Below is a list of companies who compete with Aytu BioPharma or are related in some way:
    • AIM ImmunoTech Inc (AIM)
    • Bristol-Myers Squibb Co (BMY)
    • CEL-SCI Corp (CVM)
    • enVVeno Medical Corp (NVNO)
    • Telesis Bio Inc (TBIO)

Aytu BioPharma Dividend Yield

Aytu BioPharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: -6.98% 20.38%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 8.00
Upside from Last Price: 390.8%

Major Shareholders

  • How many AYTU shares are owned by institutional investors?
    3.2M AYTU shares are owned by institutional investors
  • How many AYTU shares are owned by insiders?
    2.8M AYTU shares are owned by insiders